Literature DB >> 21954284

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.

Je-In Youn1, Michelle Collazo, Irina N Shalova, Subhra K Biswas, Dmitry I Gabrilovich.   

Abstract

MDSCs are a group of cells with potent immune-suppressive activity. These cells accumulate in many pathologic conditions and play a major role in the regulation of immune responses. The nature of MDSC remains highly debatable. In cancer, most MDSCs are represented by cells with granulocytic phenotype and morphology, G-MDSC. The relationship between G-MDSCs and Neu remains unclear. In this study, we have found that G-MDSCs, from tumor-bearing, and Neu, from tumor-free, mice share a common morphology and phenotype. However, in contrast to Neu, a substantial proportion of G-MDSCs expressed M-CSFR and a CD244 molecule. Neu had significantly higher phagocytic activity, expression of lysosomal proteins, and TNF-α than corresponding G-MDSCs, which had significantly higher activity of arginase, MPO, and ROS. In contrast to G-MDSC, neither rested nor mobilized Neu suppressed T cells. G-MDSC survived 2 days in culture in the presence of GM-CSF and within 24 h, became phenotypic and functionally similar to Neu. Tumor-associated G-MDSC shared most characteristics of splenic G-MDSC, rather then Neu. These data suggest that in cancer, despite morphological and phenotypic similarities, G-MDSCs are functionally distinct from Neu and are comprised of pathologically activated precursors of Neu.

Entities:  

Mesh:

Year:  2011        PMID: 21954284      PMCID: PMC3250305          DOI: 10.1189/jlb.0311177

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  27 in total

Review 1.  An integrated view of humoral innate immunity: pentraxins as a paradigm.

Authors:  Barbara Bottazzi; Andrea Doni; Cecilia Garlanda; Alberto Mantovani
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

2.  Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.

Authors:  Pratima Sinha; Chinonyerem Okoro; Dirk Foell; Hudson H Freeze; Suzanne Ostrand-Rosenberg; Geetha Srikrishna
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Myeloid-derived suppressor cell heterogeneity and subset definition.

Authors:  Elisa Peranzoni; Serena Zilio; Ilaria Marigo; Luigi Dolcetti; Paola Zanovello; Susanna Mandruzzato; Vincenzo Bronte
Journal:  Curr Opin Immunol       Date:  2010-02-17       Impact factor: 7.486

4.  Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.

Authors:  Jennifer S Ko; Arnold H Zea; Brian I Rini; Joanna L Ireland; Paul Elson; Peter Cohen; Ali Golshayan; Patricia A Rayman; Laura Wood; Jorge Garcia; Robert Dreicer; Ronald Bukowski; James H Finke
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

5.  Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Authors:  Cesar A Corzo; Matthew J Cotter; Pingyan Cheng; Fendong Cheng; Sergei Kusmartsev; Eduardo Sotomayor; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Authors:  Paulo C Rodriguez; Marc S Ernstoff; Claudia Hernandez; Michael Atkins; Jovanny Zabaleta; Rosa Sierra; Augusto C Ochoa
Journal:  Cancer Res       Date:  2009-02-05       Impact factor: 12.701

Review 7.  Myeloid-derived suppressor cells: linking inflammation and cancer.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

Authors:  Zvi G Fridlender; Jing Sun; Samuel Kim; Veena Kapoor; Guanjun Cheng; Leona Ling; G Scott Worthen; Steven M Albelda
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.

Authors:  Zuping Zhou; Deborah L French; Ge Ma; Samuel Eisenstein; Ying Chen; Celia M Divino; Gordon Keller; Shu-Hsia Chen; Ping-Ying Pan
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

Review 10.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

View more
  225 in total

1.  Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.

Authors:  Michael W Pickup; Philip Owens; Agnieszka E Gorska; Anna Chytil; Fei Ye; Chanjuan Shi; Valerie M Weaver; Raghu Kalluri; Harold L Moses; Sergey V Novitskiy
Journal:  Cancer Immunol Res       Date:  2017-08-03       Impact factor: 11.151

2.  Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.

Authors:  J Yan; C Tingey; R Lyde; T C Gorham; D K Choo; A Muthumani; D Myles; L P Weiner; K A Kraynyak; E L Reuschel; T H Finkel; J J Kim; N Y Sardesai; K E Ugen; K Muthumani; D B Weiner
Journal:  Cancer Gene Ther       Date:  2014-11-14       Impact factor: 5.987

Review 3.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

4.  Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.

Authors:  Eva Sahakian; John J Powers; Jie Chen; Susan L Deng; Fengdong Cheng; Allison Distler; David M Woods; Jennifer Rock-Klotz; Andressa L Sodre; Je-In Youn; Karrune V Woan; Alejandro Villagra; Dmitry Gabrilovich; Eduardo M Sotomayor; Javier Pinilla-Ibarz
Journal:  Mol Immunol       Date:  2014-08-23       Impact factor: 4.407

Review 5.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

6.  Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Authors:  Irina Lerman; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Luis Chiriboga; Chunliu Pan; Kent L Nastiuk; John J Krolewski; Aritro Sen; Stephen R Hammes
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

7.  Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer.

Authors:  Jong-Ho Choi; Yun-Suhk Suh; Yunhee Choi; Jiyeon Han; Tae Han Kim; Shin-Hoo Park; Seong-Ho Kong; Hyuk-Joon Lee; Han-Kwang Yang
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

Review 8.  Plasticity of myeloid-derived suppressor cells in cancer.

Authors:  Evgenii Tcyganov; Jerome Mastio; Eric Chen; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2018-03-14       Impact factor: 7.486

9.  Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Authors:  Xin Long; Jian Wang; Jian-Ping Zhao; Hui-Fang Liang; Peng Zhu; Qi Cheng; Qian Chen; Yan-Hui Wu; Zhan-Guo Zhang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

10.  Harmful Effects of Granulocytic Myeloid-Derived Suppressor Cells on Tuberculosis Caused by Hypervirulent Mycobacteria.

Authors:  Caio César Barbosa Bomfim; Eduardo Pinheiro Amaral; Igor Santiago-Carvalho; Gislane Almeida Santos; Érika Machado Salles; Araceli Aparecida Hastreiter; Rogério Silva do Nascimento; Fabrício M Almeida; Thatiana Lopes Biá Ventura Simão; Andreza Linhares Rezende; Mario Hiroyuki Hirata; Ricardo Ambrósio Fock; José Maria Álvarez; Elena B Lasunskaia; Maria Regina D'Império Lima
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.